Sipai Health Technology Co, Ltd
HKEX:314
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Intrinsic Value
Sipai Health Technology Co., Ltd. operates as a medical technology and health management company. [ Read More ]
The intrinsic value of one Sipai Health Technology Co, Ltd stock under the Base Case scenario is 4.78 HKD. Compared to the current market price of 6 HKD, Sipai Health Technology Co, Ltd is Overvalued by 20%.
Valuation Backtest
Sipai Health Technology Co, Ltd
Run backtest to discover the historical profit from buying and selling Sipai Health Technology Co, Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Sipai Health Technology Co, Ltd
| Current Assets | 2.7B |
| Cash & Short-Term Investments | 1.5B |
| Receivables | 440.3m |
| Other Current Assets | 724.5m |
| Non-Current Assets | 234.2m |
| Long-Term Investments | 2m |
| PP&E | 88.9m |
| Intangibles | 136m |
| Other Non-Current Assets | 7.4m |
| Current Liabilities | 1.1B |
| Accounts Payable | 340.7m |
| Accrued Liabilities | 158.5m |
| Other Current Liabilities | 556.2m |
| Non-Current Liabilities | 37.3m |
| Long-Term Debt | 38.7m |
| Other Non-Current Liabilities | -1.4m |
Earnings Waterfall
Sipai Health Technology Co, Ltd
|
Revenue
|
4.1B
CNY
|
|
Cost of Revenue
|
-3.8B
CNY
|
|
Gross Profit
|
334m
CNY
|
|
Operating Expenses
|
-957.3m
CNY
|
|
Operating Income
|
-623.3m
CNY
|
|
Other Expenses
|
-747.3m
CNY
|
|
Net Income
|
-1.4B
CNY
|
Free Cash Flow Analysis
Sipai Health Technology Co, Ltd
| CNY | |
| Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Sipai Health Technology Co, Ltd's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
Score
Sipai Health Technology Co, Ltd's profitability score is 21/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Sipai Health Technology Co, Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Score
Sipai Health Technology Co, Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Sipai Health Technology Co, Ltd
According to Wall Street analysts, the average 1-year price target for Sipai Health Technology Co, Ltd is 8.73 HKD with a low forecast of 5.45 HKD and a high forecast of 12.3 HKD.
Shareholder Return
Price
Sipai Health Technology Co, Ltd
| Average Annual Return | -25.6% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -87% |
| Market Capitalization | 4.6B HKD |
| Shares Outstanding | 753 690 300 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Sipai Health Technology Co., Ltd. operates as a medical technology and health management company. The company is headquartered in Guangzhou, Guangdong and currently employs 3,269 full-time employees. The company went IPO on 2022-12-23. The Company’s businesses include Specialty Pharmacy Business, Physician Research Assistance Business and Health Insurance Services Business. Specialty Pharmacy Business includes the operation of offline specialty pharmacies and distribution of pharmaceutical products to pharmaceutical companies and other distributors. Physician Research Assistance Business mainly provides integrated services for pharmaceutical companies to assist them in producing clinical trial data that meets the relevant regulatory standards for the pharmaceutical companies to advance to the next phase of clinical or solicit approval of a treatment by the applicable regulatory body. Health Insurance Services Business provides insurance brokerage services including distribution of various health and life insurance products on behalf of insurance carriers.
Contact
IPO
Employees
Officers
The intrinsic value of one Sipai Health Technology Co, Ltd stock under the Base Case scenario is 4.78 HKD.
Compared to the current market price of 6 HKD, Sipai Health Technology Co, Ltd is Overvalued by 20%.
You don't have any saved screeners yet
